PATENT CLAIM ANALYSIS

Application Number: 16096119
Application Type: Utility
Filing Date: 2018-10
Publication Date: 2019-05
Patent Classification: ["514", "023000"]

Abstract:
Disclosed are an amine solvate of a sodium-glucose linked transporter (SGLT) inhibitor, and a preparation method and application thereof. The SGLT inhibitor is (1S,2S,3S,4R,5S)-5-(3-((2,3-dihydrobenzo[b][1,4]dioxin-6-yl)methyl)-4-ethylbenzyl)-1-(hydroxymethyl)-6,8-dioxabicyclo[3.2.1]octane-2,3,4-triol. Further provided is a crystalline compound of the amine solvate, a pharmaceutical composition comprising the amine solvate, and an application of the amine solvate in preparing an SGLT-inhibiting pharmaceutical product.

Claim (Index 16):
The amine solvate of the compound of formula (I) according to  claim 1  or the pharmaceutical composition according to  claim 11  for use in treating or delaying the development or the attack of diabetes, diabetic retinopathy, diabetic neuropathy, diabetic nephropathy, insulin resistance, hyperglycemia, hyperinsulinemia, elevated levels of fatty acids or glycerol, hyperlipidemia, obesity, hypertriglyceridemia, X syndrome, diabetes complications, atherosclerosis or hypertension.

Metadata:
- Claim Count in Document: 10.0
- Percentile: 97.0
- Lexical Diversity: 1.78431
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: True
- Related Applications: ['15778220', '15748283', '15314458', '16065544', '15753993']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7578074660236508
- 35 USC 102 Novelty (BERT): 0.5234528342839158
- Combined Prediction Score: 0.7343720028496773
- Mean Citation Score: 275.562144
- Max Citation Score: 309.48706
- Similarity Product: 239.11014377552627

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test